Cerecin Inc.
Records under this name other than the patents Cerecin Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 6 of 6 · Back to Cerecin Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,445,535 | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II Term ended Term ended Mar 4, 2024 · From the USPTO record | Term ended | Term ended Mar 4, 2024 | From the USPTO record |
| US 8,124,589 | Use of ketogenic compounds for treatment of age-associated memory impairment Term ended Term ended Jul 14, 2021 · From the USPTO record | Term ended | Term ended Jul 14, 2021 | From the USPTO record |
| US 6,835,750 | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II Term ended Term ended May 20, 2021 · From the USPTO record | Term ended | Term ended May 20, 2021 | From the USPTO record |
| US 8,426,468 | Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism Term ended Ended no later than May 1, 2021 · From the USPTO record | Term ended | Ended no later than May 1, 2021 | From the USPTO record |
| US 8,748,400 | Use of ketogenic compounds for treatment of age-associated memory impairment Term ended Ended no later than May 1, 2021 · From the USPTO record | Term ended | Ended no later than May 1, 2021 | From the USPTO record |
| US 9,603,823 | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II Term ended Ended no later than May 1, 2021 · From the USPTO record | Term ended | Ended no later than May 1, 2021 | From the USPTO record |